Clinical Trial Update: Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Abraxane plus gemcitabine versus gemcitabine alone in locally advanced unresectable pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente | Conditions: Pancreatic Cancer Stage II | Phase 2 | Status: COMPLETED